Fellow 2013- Dr Rebecca Read

Dr Rebecca Read is a General Surgeon whose surgical training was based at Royal Prince Alfred Hospital. She received her FRACS in 2013. Prior to this she completed her medical degree at the University of Sydney and her doctorate at Oxford University.  She was the second Breast and Surgical Oncology Fellow at the Poche Centre where her work is supervised by A/Prof Andrew Spillane, Dr Kylie Snook and Dr Robyn Saw.

Rebecca was honoured to be the recipient of this Fellowship position. It allowed her to work with some of Australia’s leading breast and melanoma surgeons to gain further experience in surgical decision-making and technique. Her involvement in multidisciplinary meetings for both breast cancer and melanoma patients also provided valuable clinical experience.

She conducted a number of clinical research projects during her Fellowship.

  • One study investigates in-transit metastases in melanoma patients and part of this work was presented at The World Melanoma Congress, Hamburg 2013.
  • Rebecca will present at the Society of Surgical Onocology, Phoenix 2014, where she will discuss new operative techniques and quality assurance in melanoma surgery.
  • Another area of interest is in the increased use of neoadjuvant chemotherapy in the treatment of patients with operable breast cancer because it can provide early treatment for some patients at a time when surgical treatment options are becoming increasingly complicated.

Rebecca would like to thank The Friends of the Mater and Melanoma Institute Australia for funding this valuable Fellowship.

 Publications during Fellowship

  • Read RL, Haydu L, Saw RP, Quinn MJ, Shannon K, Spillane AJ, Stretch JR, Scolyer RA, Thompson JF. In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy. Ann Surg Oncol 2015;22(2):475-81Abstract
  • Read R, Flitcroft K, Snook K, Boyle F, Spillane A. The utility of neoadjuvant chemotherapy in the treatment of operable breast cancer. ANZ Journal of Surgery. Abstract
  • Flitcroft KLSpillane AJRead RL. Lack of appropriate imaging before breast augmentation can have serious patient consequences. Med J Aust. 2014 Mar 3;200(4):198-9. Journal
  • Read RL, et al. Neoadjuvant chemotherapy in operable breast cancer [submitted for publication; under review]
  • Read RLBambach CPSnook KL.  A rotation flap restores volume after inferomedial breast cancer excision.  ANZ J Surg 2013; 83 (7-8): 595-6.

Conference presentations during Fellowship

Read RL, Haydu L, Spillane AJ, Saw RPM, Thompson JF. The role of regional lymph node dissection in patients with in-transit melanoma. Oral presentation. 8th World Congress of Melanoma, Hamburg, Germany. 2013.

Read RL, Snook KL, Boyle FM, Spillane AJ. Expanding indications for neoadjuvant chemotherapy in patients with operable breast cnacer. Poster presentation. RACS ASC Singapore. 2014.

Read RL, Spillane AJ. Quality assurance in melanoma surgery: benchmarks for surgical audit. Poster presentation. Society of
Surgical Oncology, 67th Annual Cancer Symposium, Phoenix, Arizona. 2014.

Read RL, Spillane AJ. A minimally invasive technique for pelvic lymphadenectomy in patients with metastatic melanoma. Top rated videos: oral presentation. Society of Surgical Oncology, 67th Annual Cancer Symposium, Phoenix, Arizona. 2014.

Awards

John Collins Medal and Travel Grant, Australian and New Zealand Breast Cancer Trials Group (ANZBCTG) 2013.